Terms: = Breast cancer AND PSA AND Treatment
201 results:
1. A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
Wang Z; Ye J; Hu J; Zhang N; Yuan Y
J Cancer Res Clin Oncol; 2024 Mar; 150(3):110. PubMed ID: 38427070
[TBL] [Abstract] [Full Text] [Related]
2. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract] [Full Text] [Related]
3. What Is the Role of Nutraceutical Products in cancer Patients? A Systematic Review of Randomized Clinical Trials.
Di Napoli R; Balzano N; Mascolo A; Cimmino C; Vitiello A; Zovi A; Capuano A; Boccellino M
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513667
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor-Darolutamide.
Podgoršek E; Mehra N; van Oort IM; Somford DM; Boerrigter E; van Erp NP
Clin Pharmacokinet; 2023 Aug; 62(8):1049-1061. PubMed ID: 37458966
[TBL] [Abstract] [Full Text] [Related]
5. A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate cancer.
Pook D; Geynisman DM; Carles J; de Braud F; Joshua AM; Pérez-Gracia JL; Llácer Pérez C; Shin SJ; Fang B; Barve M; Maruzzo M; Bracarda S; Kim M; Kerloeguen Y; Gallo JD; Maund SL; Harris A; Huang KC; Poon V; Sutaria DS; Gurney H
Clin Cancer Res; 2023 Sep; 29(17):3292-3300. PubMed ID: 37339186
[TBL] [Abstract] [Full Text] [Related]
6. Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
Michalski JM; Winter KA; Prestidge BR; Sanda MG; Amin M; Bice WS; Gay HA; Ibbott GS; Crook JM; Catton CN; Raben A; Bosch W; Beyer DC; Frank SJ; Papagikos MA; Rosenthal SA; Barthold HJ; Roach M; Moughan J; Sandler HM
J Clin Oncol; 2023 Aug; 41(24):4035-4044. PubMed ID: 37315297
[TBL] [Abstract] [Full Text] [Related]
7. BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance.
Shu X; Li J; Chan UI; Su SM; Shi C; Zhang X; An T; Xu J; Mo L; Liu J; Wang Y; Li X; Deng M; Lei JH; Wang C; Tian H; Heng S; Shim JS; Zhang X; Dai Y; Yao Z; Kuang X; Lin Y; Deng CX; Xu X
Cancer Res; 2023 Aug; 83(15):2614-2633. PubMed ID: 37227919
[TBL] [Abstract] [Full Text] [Related]
8. Polysialic acid-functionalized liposomes for efficient honokiol delivery to inhibit breast cancer growth and metastasis.
Li X; Guan S; Li H; Li D; Liu D; Wang J; Zhu W; Xing G; Yue L; Cai D; Zhang Q
Drug Deliv; 2023 Dec; 30(1):2181746. PubMed ID: 36803115
[TBL] [Abstract] [Full Text] [Related]
9. Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.
Wilkins A; Gusterson B; Tovey H; Griffin C; Stuttle C; Daley F; Corbishley CM; Dearnaley D; Hall E; Somaiah N
EBioMedicine; 2023 Feb; 88():104436. PubMed ID: 36708693
[TBL] [Abstract] [Full Text] [Related]
10. Sclerosing Adenosis of the Prostate-A Benign Lesion Similar to Prostate cancer: A Case Report and Literature Review.
Yao H; Tang G; Cui Y; Wu J
Am J Mens Health; 2022; 16(6):15579883221143182. PubMed ID: 36527372
[TBL] [Abstract] [Full Text] [Related]
11. Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial.
Yap TA; Bardia A; Dvorkin M; Galsky MD; Beck JT; Wise DR; Karyakin O; Rubovszky G; Kislov N; Rohrberg K; Joy AA; Telli ML; Schram AM; Conte U; Chappey C; Stewart R; Stypinski D; Michelon E; Cesari R; Konstantinopoulos PA
JAMA Oncol; 2023 Jan; 9(1):40-50. PubMed ID: 36394849
[TBL] [Abstract] [Full Text] [Related]
12. An analysis of time trends in breast and prostate cancer mortality rates in Lithuania, 1986-2020.
Everatt R; Gudavičienė D
BMC Public Health; 2022 Sep; 22(1):1812. PubMed ID: 36151551
[TBL] [Abstract] [Full Text] [Related]
13. Combination of Goniothalamin and Sol-Gel-Derived Bioactive Glass 45S5 Enhances Growth Inhibitory Activity
Bakar SAA; Ali AM; Noor SNFM; Hamid SBS; Azhar NA; Mohamad NM; Ahmad NH
Biomed Res Int; 2022; 2022():5653136. PubMed ID: 35872839
[TBL] [Abstract] [Full Text] [Related]
14. Endogenous ROS-Mediated Covalent Immobilization of Gold Nanoparticles in Mitochondria: A "Sharp Sword" in Tumor Radiotherapy.
Zhao Y; Feng Y; Li J; Cui C; Wang A; Fang J; Zhang Y; Ye S; Mao Q; Wang X; Shi H
ACS Chem Biol; 2022 Aug; 17(8):2355-2365. PubMed ID: 35852948
[TBL] [Abstract] [Full Text] [Related]
15. Tumor-targeted delivery of honokiol via polysialic acid modified zein nanoparticles prevents breast cancer progression and metastasis.
Zhang Q; Li D; Guan S; Liu D; Wang J; Xing G; Yue L; Cai D
Int J Biol Macromol; 2022 Apr; 203():280-291. PubMed ID: 35093442
[TBL] [Abstract] [Full Text] [Related]
16. Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early breast cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial.
Braal CL; Kleijburg A; Jager A; Koolen SLW; Mathijssen RHJ; Corro Ramos I; Wetzelaer P; Uyl-de Groot CA
Clin Drug Investig; 2022 Feb; 42(2):163-175. PubMed ID: 35020170
[TBL] [Abstract] [Full Text] [Related]
17. Secreted indicators of androgen receptor activity in breast cancer pre-clinical models.
Hanamura T; Christenson JL; O'Neill KI; Rosas E; Spoelstra NS; Williams MM; Richer JK
Breast Cancer Res; 2021 Nov; 23(1):102. PubMed ID: 34736512
[TBL] [Abstract] [Full Text] [Related]
18. Lectin Affinity Chromatography for the Discovery of Novel cancer Glycobiomarkers: A Case Study with psa Glycoforms and Prostate cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract] [Full Text] [Related]
19. Genetic Aberrations of DNA Repair Pathways in Prostate cancer: Translation to the Clinic.
Ghose A; Moschetta M; Pappas-Gogos G; Sheriff M; Boussios S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575947
[TBL] [Abstract] [Full Text] [Related]
20. A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic breast cancer.
LoRusso P; Hamilton E; Ma C; Vidula N; Bagley RG; Troy S; Annett M; Yu Z; Conlan MG; Weise A
Clin Breast Cancer; 2022 Jan; 22(1):67-77. PubMed ID: 34565686
[TBL] [Abstract] [Full Text] [Related]
[Next]
